In continuation to its outcome of the Board Meeting dated November 11, 2026 with regard to Unaudited Financial Results (Standalone and Consolidated) for the Second quarter and half year ended September 30, 2026, Bal Pharma has informed that it enclosed a copy of the advertisement published in Financial Express (English) and Sanjevani (Kannada) on 12.11.2026. The copies of the aforesaid newspaper publications are enclosed.
The above information is a part of company’s filings submitted to BSE.